J. Vildé

发表

N-acetyl-β-D-Glucosaminidase (NAG) isoenzymes release from human monocyte-derived macrophages in response to zymosan and human recombinant interferon-γ

F. Raffi, R. Bourbouze, G. Dameron, 1991 .

Randomized Phase II Trial of Atovaquone with Pyrimethamine or Sulfadiazine for Treatment of Toxoplasmic Encephalitis in Patients with Acquired Immunodeficiency Syndrome: ACTG 237/ANRS 039 Study

B. Luft, P. Morlat, C. Leport, 2002 .

Fifty cases of late prosthetic valve endocarditis: improvement in prognosis over a 15 year period.

C. Leport, C. Gaudebout, J. Vildé, 1987, British heart journal.

Lactoferrin deficiency as a consequence of a lack of specific granules in neutrophils from a patient with recurrent infections. Detection by immunoperoxidase staining for lactoferrin and cytochemical electron microscopy.

C. Griscelli, J. Vildé, D. Mason, 1980, The American journal of pathology.

Definite streptococcus bovis endocarditis: characteristics in 20 patients.

C. Leport, X. Duval, C. Perronne, 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Activities of WIN-57273, minocycline, clarithromycin, and 14-hydroxy-clarithromycin against Mycobacterium avium complex in human macrophages

C. Truffot-Pernot, J. Grosset, J. Pocidalo, 1992, Antimicrobial Agents and Chemotherapy.

Activities of sparfloxacin, azithromycin, temafloxacin, and rifapentine compared with that of clarithromycin against multiplication of Mycobacterium avium complex within human macrophages

C. Truffot-Pernot, J. Grosset, J. Pocidalo, 1991, Antimicrobial Agents and Chemotherapy.

Use of normal C57BL/6 mice with established Mycobacterium avium infections as an alternative model for evaluation of antibiotic activity

C. Truffot-Pernot, J. Grosset, J. Pocidalo, 1995, Antimicrobial agents and chemotherapy.

Lower survival in AIDS patients receiving dapsone compared with aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia. Study Group.

F. Raffi, C. Chidiac, O. Patey, 1995, The Journal of infectious diseases.

Efficacy of granulocyte colony-stimulating factor and RU-40555 in combination with clarithromycin against Mycobacterium avium complex infection in C57BL/6 mice

J. Grosset, J. Pocidalo, C. Perronne, 1993, Antimicrobial Agents and Chemotherapy.

Activities of clarithromycin, sulfisoxazole, and rifabutin against Mycobacterium avium complex multiplication within human macrophages

C. Truffot-Pernot, J. Grosset, J. Pocidalo, 1990, Antimicrobial Agents and Chemotherapy.

Activities of roxithromycin against Mycobacterium avium infections in human macrophages and C57BL/6 mice

N. Lounis, J. Grosset, J. Pocidalo, 1995, Antimicrobial agents and chemotherapy.

Use of corticosteroids in glomerulonephritis related to infective endocarditis: three cases and review.

C. Leport, M. Delahousse, X. Duval, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Predictive value of cytomegalovirus viraemia for the occurrence of CMV organ involvement in AIDS

F. Brun-Vézinet, C. Leport, D. Salmon, 1990, Journal of medical virology.

Effect of subinhibitory concentrations of antimicrobial agents on adherence to silicone and hydrophobicity of coagulase-negative staphylococci.

C. Leport, J. Pocidalo, J. Vildé, 1996, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Factors Associated with Mortality in Human Immunodeficiency Virus Type 1–Infected Adults Initiating Protease Inhibitor–Containing Therapy: Role of Education Level and of Early Transaminase Level Elevation (APROCO–ANRS EP11 Study)

R. Salamon, L. Cuzin, F. Raffi, 2002 .

Cytomegalovirus (CMV) viremia and the CD4+ lymphocyte count as predictors of CMV disease in patients infected with human immunodeficiency virus.

F. Brun-Vézinet, C. Leport, C. Mandet, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Factors associated with mortality in human immunodeficiency virus type 1-infected adults initiating protease inhibitor-containing therapy: role of education level and of early transaminase level elevation (APROCO-ANRS EP11 study). The Antiprotéases Cohorte Agence Nationale de Recherches sur le SIDA

R. Salamon, L. Cuzin, F. Raffi, 2002, The Journal of infectious diseases.

Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy.

C. Leport, C. Estellat, X. Duval, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Fever of unknown origin in HIV‐infected patients: a critical analysis of a retrospective series of 57 cases

C. Leport, F. Bissuel, C. Perronne, 1994, Journal of internal medicine.

Should pulmonary tuberculosis be an AIDS-defining diagnosis in patients infected with HIV?

C. Leport, C. Perronne, J. Vildé, 1992, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

High levels of IL‐10 and determination of other cytokines and chemokines in HIV‐associated haemophagocytic syndrome

D. Dormont, C. Leport, O. Benveniste, 2000, Clinical and experimental immunology.

Sustained bacteremia in 26 patients with a permanent endocardial pacemaker: assessment of wire removal.

F. Raffi, C. Michelet, C. Leport, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Congenital and acquired lactoferrin deficiencies in neutrophils.

C. Griscelli, J. Vildé, J. Hakim, 1982, Advances in Experimental Medicine and Biology.

Efavirenz-Induced Decrease in Plasma Amprenavir Levels in Human Immunodeficiency Virus-Infected Patients and Correction by Ritonavir

C. Leport, R. Farinotti, G. Peytavin, 2000, Antimicrobial Agents and Chemotherapy.

Resting energy expenditure in human immunodeficiency virus-infected patients: comparison between patients with and without secondary infections.

E. Casalino, J. Melchior, F. Vachon, 1993, The American journal of clinical nutrition.

Experimental colonization of a polyester vascular graft with Staphylococcus aureus: a quantitative and morphologic study.

R. Guidoin, C. Leport, C. Lebrault, 1988, Journal of vascular surgery.

The efficacy and safety of zidovudine with or without acyclovir in the treatment of patients with AIDS-related complex

C. Farthing, D. Cooper, N. Clumeck, 1991 .

Cryptococcal meningitis in AIDS patients. A pilot study of fluconazole therapy in 52 patients.

A. Datry, B. Dupont, I. Hilmarsdóttir, 1990 .

[Lumbar spondylodiscitis after insertion of a Mobin-Uddin caval "umbrella" filter (author's transl)].

J. Vildé, B. Andréassian, Y. Courouble, 1981, La Nouvelle presse medicale.

Efficacy of zidovudine in preventing relapses of Salmonella bacteremia in AIDS.

C. Leport, D. Salmon, J. Vildé, 1991, The Journal of infectious diseases.

Cytomegalovirus neuropathy in acquired immunodeficiency syndrome: A clinical and pathological study

C. Lacroix, C. Leport, M. Torchet, 1991, Annals of neurology.

Clinical and echocardiographic observations in pulmonary valve endocarditis.

M. Wolff, A. Crémieux, M. Malergue, 1985, The American journal of cardiology.

Survival after AIDS-defining events in patients with < 200 lymphocytes CD4+ x 10(6)/L who are toxoplasmosis antibody positive. ANRS 005/ACTG 154 Trial Group.

R. Salamon, B. Luft, P. Morlat, 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

High risk of HIV disease progression after infection through a sexual partner with AIDS

C. Rouzioux, L. Meyer, F. Boufassa, 1996, AIDS.

Clinical and bacterial features of infections caused by Streptococcus milleri.

C. Leport, J. Molina, C. Michon, 1991, Scandinavian journal of infectious diseases.

Partial Myeloperoxidase Deficiency in a Case of Preleukaemia

B. Dreyfus, J. Vildé, J. Breton‐Gorius, 1975, British journal of haematology.

Association of Epstein-Barr virus with lethal midline granuloma.

G. de Thé, C. Leport, C. Perronne, 1985, The New England journal of medicine.

Low rate of Clostridium difficile colonization in ambulatory and hospitalized HIV-infected patients in a hospital unit: a prospective survey.

C. Leport, J. Mainardi, F. Goldstein, 1998, The Journal of infection.

Intestinal infections in patients with acquired immunodeficiency syndrome

J. Pignon, B. Régnier, J. Vildé, 1989, Digestive Diseases and Sciences.

Upper respiratory tract involvement in the course of diffuse infiltrative lymphocytosis syndrome in HIV-1-infected patients: report of 2 cases.

H. Adle-Biassette, S. Jacobelli, P. Yeni, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Upper Respiratory Tract Involvement in the Course of Diffuse Inﬁltrative Lymphocytosis Syndrome in HIV-1– Infected Patients: Report of 2 Cases

H. Adle-Biassette, S. Jacobelli, P. Yeni, 2005 .

Peroxidatic activity distinct from myeloperoxidase in human monocytes cultured in vitro and in alveolar macrophages.

W. Vainchenker, F. Basset, J. Vildé, 1982, Advances in experimental medicine and biology.

Cytochemical and ultrastructural studies of aberrant granules in the neutrophils of two patients with myeloperoxidase deficiency during a preleukemic state: relationship to abnormal bactericidal activity.

B. Dreyfus, J. Vildé, J. Breton‐Gorius, 1976, Nouvelle revue francaise d'hematologie; blood cells.

Failure of spiramycin to prevent neurotoxoplasmosis in immunosuppressed patients.

C. Katlama, B. Régnier, C. Leport, 1986, JAMA.

N-acetyl-beta-D-glucosaminidase (NAG) isoenzymes release from human monocyte-derived macrophages in response to zymosan and human recombinant interferon-gamma.

F. Raffi, R. Bourbouze, G. Dameron, 1991, Clinica chimica acta; international journal of clinical chemistry.

Docetaxel in anthracycline‐pretreated AIDS‐related Kaposi's sarcoma: a retrospective study

C. Leport, B. Crickx, V. Descamps, 2005, The British journal of dermatology.

Cure of streptococcal endocarditis with six days of antibiotic therapy.

J. Vildé, F. Bricaire, J. Frottier, 1986, JAMA.

Response to fluconazole by 23 patients with human immunodeficiency virus infection and oral candidiasis: pharmacological and mycological factors

C. Leport, C. Chochillon, F. Damond, 1996, Antimicrobial agents and chemotherapy.

Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome: Efficacy of long-term continuous therapy

C. Katlama, B. Régnier, F. Raffi, 1988 .

Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients

P. Massip, C. Leport, P. Lutun, 1989, Antimicrobial Agents and Chemotherapy.

Sparfloxacin, ethambutol, and cortisol receptor inhibitor RU-40 555 treatment for disseminated Mycobacterium avium complex infection of normal C57BL/6 mice

C. Truffot-Pernot, J. Grosset, J. Pocidalo, 1992, Antimicrobial Agents and Chemotherapy.

Life Expectancy in Hospitalized Patients with AIDS: Prognostic Factors on Admission

J. le Gall, C. Leport, P. Flandre, 1996, Journal of palliative care.

Resting energy expenditure is increased in stable, malnourished HIV-infected patients.

C. Leport, J. Melchior, F. Vachon, 1991, The American journal of clinical nutrition.

Role of IgG and complement component C5 in the initial course of experimental cryptococcosis.

F. Dromer, P. Yeni, C. Perronne, 1989, Clinical and experimental immunology.

Chloroquine does not enhance the activity of clarithromycin against multiplication of Mycobacterium avium within human macrophages.

C. Truffot-Pernot, J. Grosset, J. Pocidalo, 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Hypoglycaemia and Diabetes Mellitus Following Parenteral Pentamidine Mesylate Treatment in AIDS Patients

C. Leport, C. Perronne, R. Assan, 1990, Diabetic medicine : a journal of the British Diabetic Association.

Direct activation of human monocyte-derived macrophages by a bacterial glycoprotein extract inhibits the intracellular multiplication of virulent Legionella pneumophila serogroup 1

P. Rajagopalan, J. Pocidalo, J. Vildé, 1987, Infection and immunity.

Fifty casesoflate prosthetic valveendocarditis: improvement inprognosis over a 15year period

C. Leport, C. Gaudebout, J. Vildé, 2017 .

Empiric antituberculosis treatment: benefits for earlier diagnosis and treatment of tuberculosis.

C. Leport, X. Anglaret, C. Perronne, 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Long term evolution of adult onset Still ' s disease seen in an infectious diseases

C. Leport, B. Godeau, C. Perronne, 2022 .

Tubulopathy Consecutive to Tenofovir-containing Antiretroviral Therapy in Two Patients Infected with Human Immunodeficiency Virus-1

C. Leport, G. Peytavin, X. Duval, 2004, Scandinavian journal of infectious diseases.

An open study of the pyrimethamine-clindamycin combination in AIDS patients with brain toxoplasmosis.

C. Leport, S. Bastuji‐Garin, D. Salmon, 1989, The Journal of infectious diseases.

Pyogenic and tuberculous spondylodiskitis (vertebral osteomyelitis) in 80 adult patients.

C. Leport, M. Kahn, C. Perronne, 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[Diffuse persistent lymphadenopathies with opportunistic infections in a homosexual patient].

B. Caillou, A. Andremont, J. Vildé, 1983, Presse medicale.

Varicella in Patients Infected With the Human Immunodeficiency Virus

M. Lazanas, C. Leport, D. Salmon, 1990 .

Varicella in patients infected with the human immunodeficiency virus.

M. Lazanas, C. Leport, D. Salmon, 1990, Archives of dermatology.

Comparative postantibacterial activities of pefloxacin, ciprofloxacin, and ofloxacin against intracellular multiplication of Legionella pneumophila serogroup 1

J. Pocidalo, G. Dameron, J. Vildé, 1990, Antimicrobial Agents and Chemotherapy.

Inhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents

P. Rajagopalan, J. Vildé, E. Dournon, 1986, Antimicrobial Agents and Chemotherapy.

Increased risk of toxoplasmic encephalitis in human immunodeficiency virus-infected patients with pyrimethamine-related rash. ANRS 005-ACTG 154 Trial Group. Agence Nationale de Recherche sur le SIDA (ANRS-INSERM) and the NIAID-AIDS Clinical Trials Group.

R. Salamon, B. Luft, P. Morlat, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Bacterial prostatitis in patients infected with the human immunodeficiency virus.

C. Leport, F. Rousseau, D. Salmon, 1989, The Journal of urology.

Failure of valacyclovir for herpes zoster in a moderately immunocompromised HIV-infected patient.

C. Leport, A. Gervais, X. Duval, 2004, AIDS patient care and STDs.

Cytomegalovirus colitis in HIV‐1-infected patients: a prospective research in 55 patients

C. Leport, J. Vildé, H. Mentec, 1994, AIDS.

[Skin manifestations of immune restoration syndrome in treated tuberculosis].

B. Crickx, V. Descamps, M. Grossin, 2001, Annales de dermatologie et de venereologie.

Efficacy of pefloxacin in comparison with erythromycin in the treatment of experimental guinea pig legionellosis.

P. Rajagopalan, J. Pocidalo, J. Vildé, 1986, The Journal of antimicrobial chemotherapy.

Salivary cytomegalovirus (CMV) shedding, glycoprotein B genotype distribution, and CMV disease in human immunodeficiency virus-seropositive patients.

F. Brun-Vézinet, C. Leport, F. Bissuel, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Necrotizing retinitis and cerebral vasculitis due to varicella-zoster virus in patients infected with the human immunodeficiency virus.

C. Leport, F. Rousseau, C. Perronne, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[Pharmacokinetics and tolerance of ceftriaxone after subcutaneous administration].

J. Pocidalo, J. Vildé, F. Bricaire, 1988, Pathologie-biologie.

Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B.

P. Marcellin, D. Valla, C. Degott, 2002, Gastroenterology.

Use of efavirenz is not associated with a higher risk of depressive disorders: a substudy of the randomized clinical trial ALIZE-ANRS 099.

J. Cassuto, G. Chêne, J. Molina, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The efficacy and safety of zidovudine with or without acyclovir in the treatment of patients with AIDS-related complex. The European-Australian Collaborative Group.

C. Farthing, D. Cooper, N. Clumeck, 1991, AIDS (London).

Hepatitis E antibodies and HIV status

F. Brun-Vézinet, C. Leport, F. Bissuel, 1996, The Lancet.

Effect of a 14-day course of foscarnet on cytomegalovirus (CMV) blood markers in a randomized study of human immunodeficiency virus-infected patients with persistent CMV viremia. Agence National de Recherche du SIDA 023 Study Group.

F. Brun-Vézinet, C. Leport, I. Carrière, 1999, Clinical Infectious Diseases.

Comparative Trial of Acyclovir and Vidarabine in Disseminated Varicella‐Zoster Virus Infections in Immunocompromised Patients

F. Brun-Vézinet, C. Leport, J. Vildé, 1986, Journal of medical virology.

Cytomegalovirus resistant to foscarnet: clinicovirologic correlation in a patient with human immunodeficiency virus.

F. Brun-Vézinet, C. Leport, C. Perronne, 1993, The Journal of infectious diseases.

Importance of Baseline Prognostic Factors With Increasing Time Since Initiation of Highly Active Antiretroviral Therapy: Collaborative Analysis of Cohorts of HIV-1-Infected Patients

Anne M Johnson, A. Trkola, J. Sterne, 2007, Journal of acquired immune deficiency syndromes.

Two episodes of acute renal failure, rhabdomyolysis, and severe hepatitis in an AIDS patient successively treated with ritonavir and indinavir.

C. Leport, O. Benveniste, X. Duval, 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Herpes simplex virus type 2 DNA in cerebrospinal fluid of a woman with recurrent meningitis.

C. Leport, F. Rozenberg, O. Lortholary, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Amprenavir Inhibitory Quotient and Virological Response in Human Immunodeficiency Virus-Infected Patients on an Amprenavir-Containing Salvage Regimen without or with Ritonavir

C. Leport, F. Clavel, G. Peytavin, 2002, Antimicrobial Agents and Chemotherapy.

Low prevalence of active parvovirus B19 infection in HIV-infected patients

C. Leport, F. Morinet, M. Leruez-Ville, 1997, European Journal of Clinical Microbiology and Infectious Diseases.

Predictive value of Toxoplasma gondii antibody titres on the occurrence of toxoplasmic encephalitis in HIV‐infected patients

R. Salamon, B. Luft, P. Morlat, 1996, AIDS.

Treatment of acute toxoplasmosis with intravenous clindamycin

J. McCutchan, B. Luft, P. Morlat, 1991, European Journal of Clinical Microbiology and Infectious Diseases.

[Tuberculous spinal arachnoiditis. Value of intrathecal corticosteroid therapy].

D. Salmon, J. Vildé, F. Bricaire, 1989, Presse medicale.

Antibiotic prophylaxis of late bacteremic vascular graft infection in a dog model.

C. Leport, C. Lebrault, J. Pechère, 1990, Annals of vascular surgery.

Mechanisms of ceftriaxone prophylaxis against late bacteremic vascular graft infection caused byStaphylococcus aureus in a dog model

C. Leport, C. Lebrault, J. Pechère, 1991, Annals of vascular surgery.

Ruptured mycotic pulmonary artery aneurysm: an unusual complication of right-sided endocarditis.

B. Régnier, M. Wolff, C. Leport, 1998, Scandinavian journal of infectious diseases.

[Chronic bone infections after surgery. Treatment with the new quinolones].

C. Leport, B. Godeau, D. Salmon, 1989, Presse medicale.

[Chronic familial granulomatosis].

J. Vildé, R. Bastin, F. Vildé, 1970, Annales de medecine interne.

Nitroblue tetrazolium reduction by human macrophages: studies in chronic granulomatous disease.

J. Vildé, F. Vildé, 1976, Advances in experimental medicine and biology.

INCIDENCE OF COLONIC LESIONS IN STREPTOCOCCUS BOVIS AND ENTEROCOCCAL ENDOCARDITIS

C. Leport, J. Vildé, A. Bure, 1987, The Lancet.

Natural history of serum HIV-1 RNA levels in 330 patients with a known date of infection

C. Rouzioux, L. Meyer, C. Tamalet, 2000, AIDS.

Cytomegalovirus colitis in patients with acquired immunodeficiency syndrome

C. Katlama, C. Rouzioux, B. Régnier, 1988, Digestive Diseases and Sciences.

Possible Mechanism of Toxicity of Zidovudine by Induction of Apoptosis of CD4+ and CD8+ T-Cells in Vivo

C. Leport, J. Estaquier, J. Lelièvre, 2001, European Journal of Clinical Microbiology and Infectious Diseases.

Pericarditis Associated with Legionnaires' Disease in a Bone Marrow Transplant Recipient

F. Lisovoski, O. Lortholary, C. Perronne, 1994 .

[Myocardial localisation of tuberculosis: the diagnostic value of cardiac MRI].

C. Leport, J. Laissy, J. Vildé, 2005, Presse medicale.

Differences in the respiratory burst of human polymorphonuclear leukocytes induced by virulent and avirulent Legionella pneumophila serogroup 1.

J. Pocidalo, J. Vildé, E. Dournon, 1992, Journal of bioluminescence and chemiluminescence.

Pyrimethamine for primary prophylaxis of toxoplasmic encephalitis in patients with human immunodeficiency virus infection: a double-blind, randomized trial. ANRS 005-ACTG 154 Group Members. Agence Nationale de Recherche sur le SIDA. AIDS Clinical Trial Group.

R. Salamon, B. Luft, P. Morlat, 1996, The Journal of infectious diseases.

Determination of indinavir and nelfinavir trough plasma concentration efficacy thresholds according to virological response in HIV‐infected patients

F. Brun-Vézinet, C. Leport, G. Peytavin, 2004, HIV medicine.

[Acute articular rheumatism: physiopathology, clinical aspects].

J. Vildé, P. Longuet, 1992, La Revue du praticien.

Clarithromycin, Minocycline, and Rifabutin Treatments before and after Infection of C57BL/6 Mice with Mycobacterium avium

J. Grosset, J. Pocidalo, C. Perronne, 1993, Antimicrobial Agents and Chemotherapy.

Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium avium

J. Grosset, J. Pocidalo, C. Perronne, 1993, Antimicrobial Agents and Chemotherapy.

Ultrastructural and cytochemical changes induced by short and prolonged culture of human monocytes.

W. Vainchenker, J. Vildé, J. Guichard, 1980, Journal of the Reticuloendothelial Society.

Maintenance therapy with cotrimoxazole for toxoplasmic encephalitis in the era of highly active antiretroviral therapy

C. Leport, O. Pajot, F. Mentré, 2004, AIDS.

Role of immune serum and complement in stimulation of the metabolic burst of human neutrophils by Plasmodium falciparum

D. Salmon, J. Vildé, B. Andrieu, 1986, Infection and immunity.

Primary cytomegalovirus infection associated with the onset of ulcerative colitis

C. Leport, O. Lortholary, C. Perronne, 1993, European Journal of Clinical Microbiology and Infectious Diseases.

[Brucella hepatitis with caseous necrosis].

B. Dupont, C. Lapresle, C. Marsac, 1971, Lyon medical.

Physiopathologie des infections Salmonelles

P. Lagrange, J. Vildé, É. Koskas, 1978 .

Long term evolution of adult onset Still's disease seen in an infectious diseases department.

C. Leport, B. Godeau, M. Kahn, 1991, Annals of the rheumatic diseases.

ASSOCIATION INFECTION A VIH ET LEPRE

Pierre Vabres, J. Brion, J. Vildé, 1991 .

Unexplained fever and chronic fatigue: abnormal circadian temperature pattern.

C. Leport, J. Vildé, M. Janowski, 1992, The European journal of medicine.

Decreases in plasma TNF‐α level and IFN‐γ mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL‐2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV‐infected patients

D. Dormont, C. Leport, O. Benveniste, 2003, Clinical and experimental immunology.

Long-term follow-up of patients with AIDS on maintenance therapy for toxoplasmosis

C. Leport, J. Vildé, T. Niyongabo, 1991, European Journal of Clinical Microbiology and Infectious Diseases.

Clarithromycin-minocycline combination as salvage therapy for toxoplasmosis in patients infected with human immunodeficiency virus

C. Leport, C. Perronne, J. Vildé, 1995, Antimicrobial agents and chemotherapy.

Levels of pyrimethamine in serum and penetration into brain tissue in humans.

C. Leport, A. Meulemans, G. Dameron, 1992, AIDS.

Pyrimethamine-clarithromycin combination for therapy of acute Toxoplasma encephalitis in patients with AIDS

P. Morlat, C. Leport, J. Vildé, 1991, Antimicrobial Agents and Chemotherapy.

Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy.

C. Katlama, B. Régnier, F. Raffi, 1988, The American journal of medicine.

Dapsone and HIV-1 replication in primary cultures of lymphocytes and monocyte-derived macrophages.

D. Dormont, X. Duval, P. Clayette, 1997, AIDS (London).

[Risk factors of the occurrence of cerebral toxoplasmosis in patients with HIV infection. Definition of indications of primary prevention. Proposals of the Toxoplasmosis and other protozoan infections Group. Coordinated action N.5 - 1996 February].

P. Ambroise‐Thomas, C. Katlama, F. Derouin, 1996, Presse medicale.

Recurrent Staphylococcus aureus extracerebral infections complicating hereditary hemorrhagic telangiectasia (Osler-Rendu-Weber disease).

C. Leport, X. Duval, V. Le Moing, 2001, The American journal of medicine.

Treatment of Toxoplasmic Encephalitis in Patients with AIDS

N Clumeck, J. McCutchan, B. Luft, 1992, Annals of Internal Medicine.

Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS

P. Morlat, F. Raffi, C. Leport, 1993, European Journal of Clinical Microbiology and Infectious Diseases.

Clindamycin for toxoplasma encephalitis in AIDS

J. Remington, J. Vildé, 1991, The Lancet.

[Usefulness of folinic acid in cytopenia induced by antiparasitic drugs in AIDS patients].

C. Leport, J. Vildé, T. Niyongabo, 1991, Presse medicale.

[Peripheral neuropathy in relation to LAV/HTLV III retrovirus infection. A clinical, anatomical and immunological study. 5 cases].

J. Hauw, F. Brun-Vézinet, C. Leport, 1987, Presse medicale.

[Vancomycin in meningitis caused by penicillin G resistant Streptococcus pneumoniae].

C. Leport, C. Perronne, J. Vildé, 1993, Presse medicale.

L’obligation vaccinale en question

J. Vildé, 2015 .

Erratum: Clarithromycin, minocycline, and rifabutin treatments before and after infection of C57BL/6 mice with Mycobacterium avium (Antimicrobial Agents and Chemotherapy 37:8 (1690))

J. Grosset, J. Pocidalo, C. Perronne, 1993 .

[Pneumopathies caused by Streptococcus pneumoniae in 27 HIV infected patients].

C. Leport, X. Duval, C. Perronne, 1995, Presse medicale.

[Visceral leishmaniasis disclosed by histiocytosis with erythrophagocytosis].

M. Lazanas, G. Arapakis, C. Perronne, 1990, Presse medicale.

Acute toxoplasmic hepatitis in a patient with AIDS.

J. Brion, H. Pelloux, M. Micoud, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039.

B. Luft, P. Morlat, C. Leport, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Modalities of palliative care in hospitalized patients with advanced AIDS

C. Leport, J. Vildé, P. Moulin, 2000, AIDS care.

Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team.

B. Luft, J. Fuhrer, C. Leport, 1993, The New England journal of medicine.

An Example of Nonrandom Missing Data for Hepatitis C Virus Status in a Prognostic Study Among HIV-Infected Patients

H. Jacqmin-Gadda, L. Cuzin, C. Leport, 2004, HIV clinical trials.

Endocarditis due to Pasteurella multocida with glomerulonephritis.

B. Fantin, D. Salmon, J. Vildé, 1989, The American journal of medicine.

Potentiation of chloroquine activity against Plasmodium falciparum by the peroxidase-hydrogen peroxide system

J. Le bras, D. Salmon, J. Vildé, 1990, Antimicrobial Agents and Chemotherapy.

Susceptibility of Plasmodium falciparum to a peroxidase-mediated oxygen-dependent microbicidal system

J. Le bras, D. Salmon, J. Vildé, 1988, Infection and immunity.

Evolution of Protease and Reverse Transcriptase Inhibitor Resistance-Associated Mutations in HIV-1-Infected Protease Inhibitor-Treated Patients with Persistent Low Viraemia

C. Leport, G. Peytavin, D. Descamps, 2005, Antiviral therapy.

Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 Trial Group.

R. Salamon, B. Luft, C. Leport, 1998, Controlled clinical trials.

[Update on consensual proposals (1993 February). Role of cotrimoxazole in the primary prevention of toxoplasmosis in patients with HIV infection].

P. Ambroise‐Thomas, C. Katlama, F. Derouin, 1993, Annales de medecine interne.